patents bpc 157 BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven Sample of patents with BPC

Provides immediate and complete bioavailability

Due to its simple administration and the low risk of complications, autologous bone marrow applied locally and, in particular, intramuscularly administered osteogenous substances such as TRIS-BPC157, are advantageous over other more complex surgical methods (i.e., bone grafts, vascularized bone grafts, method of Ilizarov) for the treatment of healing impairments in humans

& Steadman, R

Rotate injection sites to prevent skin irritation

Using Quicksilver Scientifics advanced liposomal delivery for rapid and comprehensive absorption, this peptide complex has been shown to support broad-spectrum inflammatory modulating activity, tissue repair, and display antimicrobial effects

Until an approval decision is issued, CagriSema remains investigational in the U.S